SundayNov 04, 2007 5:25 am

November 5th CEOcast Weekly Newsletter

11/04/2007 VOLUME 324 Companies featured in this edition of the newsletter: ACCP, ACTC, AVGO, CBMC, CGXP, CHIP, CLXS, CVM, DOC, ENZ, GNBT, HYTM, ISON, ITUI, MBND, MSHI, PBIO, PLKH, RVEP, SCLL, SMGY, XCPL There was certainly no shortage of news for the financial community to digest last week, and the market’s volatility was an apparent indicator. The Dow lost 211 points for the week, lowering its annual gain to 9.0%. The Nasdaq bucked the trend, adding 6 points for the week, and raising its annual return to 16.3%. The S&P lost 25 points, trimming its yearly advance to 6.4%. The…

Continue Reading

SaturdayNov 03, 2007 5:33 am

StockGuru Blog: China Media Group (CHMD) Continues to Broaden Its Media Interests in China

StockGuru Profile NEWS BLOGS What you need to know! Investing in CHINA Makes Good Sense! CHMD is becoming a true media group with a broad range of interests in China. This company continues to add dimension to their media interests in China which are incredibly broad ranging. While the individual accomplishments are impressive it is important to stand back and take an overall look at this company. Each incremental success adds to the over-arching success of the company. It is completely reasonable to assume that the individual elements of this company will not only strengthen the company but are the…

Continue Reading

FridayNov 02, 2007 6:08 pm

IDM Pharma, Inc. (IDMI) Updates Shareholders on Cancer Clinical Trial

IDM Pharma, Inc. (IDMI) updated shareholders on results from the Phase 2 UVIDEM® (IDD-3) melanoma vaccine clinical trial (DC-MEL-202). These updated clinical trial results have shown that the investigational agent "UVIDEM" induction into human immune systems was well tolerated with patients suffering advanced melanoma. The data was presented during a poster session at the International Society for Biological Therapy of Cancer (iSBTc) annual meeting today in Boston. "There is a distinct need in the medical community for new treatments for metastatic melanoma," said Dr. Antoni Ribas, associate professor of medicine and surgery at UCLA and associate director of tumor immunology at…

Continue Reading

FridayNov 02, 2007 6:06 pm

Fox Petroleum (FXPE.OB) Enters into an Agreement to Acquire Additional Property

Fox Petroleum Inc. (FXPE.OB) announced that it has signed an agreement to acquire approximately 5,000 acres of additional land in the company's already pertinent North Slope Property. This will increase land acreage from 32,000 acres to 37,000 acres, which is a significant development for the company. According to the terms of this agreement, Fox will acquire a 100% working interest on these new leases leases; on which there is a 5% ORRI to the original assignees, Mr Daniel Donkel and Mr Samuel Cade, and a state royalty of 16.67%. "We're delighted to announce that we have signed the agreement to…

Continue Reading

FridayNov 02, 2007 6:04 pm

NexMed, Inc. (NEXM) Appoints Hem Pandya as Chief Operating Officer

NexMed, Inc. (NEXM), a developer of innovative products based on the company's proprietary NexACT drug delivery technology, announced that Hem Pandya has been elected as the company's Chief Operating Officer. Mr. Pandya will fill the company's newly created position and report directly to Chief Executive Officer, Vivian Liu. Mr. Pandya recently served as Chief Commercial Officer for Putney, Inc., a start-up veterinary pharmaceutical company. Previous to this position, Mr. Pandya served as Senior Vice President of Business Development and Strategic Alliances for Andrx Pharmaceuticals, Inc., where he was in charge of licensing and co-development opportunities with various partners. Ms. Liu, CEO…

Continue Reading

FridayNov 02, 2007 6:02 pm

Cyplasin Biomedical Ltd (CYPL.OB) Granted New U.S. Patent

Cyplasin Biomedical Ltd (CYPL.OB) announced that the company has been awarded a new U.S. Patent application entitled "Cytotoxic Cyplasin of the Sea Hare, Aplysia punctata, cDNA Cloning and Expression of Bioreactive Recombinants" earlier today. This patent, US 7,271,242 B2, was granted to cover the production of a cytotoxic protein by mammalian cells and the use these cells to treat cancer. Professor Christian Petzelt, Chief Scientific Officer of Cyplasin Biomedical Ltd., commented, "This patent is an important milestone to define our intellectual property for the production method of the cytotoxic cyplasin and related proteins and its application as a substance to…

Continue Reading

FridayNov 02, 2007 12:20 pm

ECOtality, Inc. (ETLY.OB) Appoints Slade Mead to Board of Directors

ECOtality announced today that it has appointed Mr. Slade Mead to the Board of Directors. He is a lawyer, professional sports consultant and former Arizona State Senator. Mr. Mead has won multiple awards, including Arizona School Board Legislator of the Year, Arizona Women’s Political Caucus Legislator of the Year, and Arizona Career Technical Education Policy Maker of the Year. Jonathan Read, President & CEO of ECOtality, stated, “We are pleased to welcome Mr. Mead to the ECOtality Board of Directors. Mr. Mead possesses a broad legal and political background with tremendous expertise in government relations that will further strengthen the…

Continue Reading

FridayNov 02, 2007 11:59 am

ShotPak, Inc. (SHTP.PK) Expands Distribution Network to the State of Tennessee

ShotPak announced today that it has signed a contract for the distribution of their STR8UP shots throughout the state of Tennessee. The product line to be introduced includes the company’s premium Vodka, high end Whisky, premium Rum and quality Tequila as well as its premium Vodka flavored shots. Ignus Hattingh, Vice President of Sales, stated, “We are very excited about adding distribution throughout Tennessee. We are confident that the consumers throughout the United States will quickly help to make ShotPak a household name once our products hit the shelves.” Let us hear your thoughts: ShotPak Inc Message Board

Continue Reading

FridayNov 02, 2007 11:55 am

StockGuru Trade Alert: Profile Stock Hemisphere Gold (HPGI) Up as Much as 45% from Yesterday and 77% from Wednesday

StockGuru Trade Alert: Profile Stock Hemisphere Gold (HPGI) Up as Much as 45% from Yesterday and 77% from Wednesday View the StockGuru Profile for HPGI: http://www.stockguru.com/profiles/hpgi/ Disclosure: Pentony Enterprises LLC has been compensated $12,000 for profile coverage. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market…

Continue Reading

FridayNov 02, 2007 8:50 am

StockGuru Stocks to Watch for Friday, November 2, 2007 Featuring Dutch Gold Resources, Universal Energy, Phantom Fiber, Intelligentias, and Advanced Medical Isotope

Dutch Gold Resources, Inc. (OTC: DGRI)Dutch Gold Resources, Inc. (OTC: DGRI) - Thursday’s shares stayed even at $1.12. 11,356 shares were traded. Dutch Gold Resources announced October 4th that it discovered new ore bodies in previously unexplored acreage in its Benton Mine. The Company reports that it has struck multiple vein structures to the South of existing production areas following the recent deployment of its new Hagby ONRAM 1000/3 Core Drill. Dan Hollis, Chief Executive Officer of Dutch Gold Resources, stated, “Our geology staff and our drilling teams are doing an excellent job putting to use and leveraging the expanded…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered